Progressive pulmonary fibrosis (PPF) is an increasingly recognised condition, defined in 2022 to address the progression of ...

BERLIN, Oct. 15, 2024 /PRNewswire/ -- Boehringer Ingelheim, a biopharmaceutical company ... King Risk Partners, a major insurance broker in the United States, is excited to announce the acquisition of ...

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over ...

The deal settles 80,000 US court cases related to allegations that Zantac was contaminated with a suspected carcinogen.

Boehringer Ingelheim focuses on targeting the proteins involved in this process as a promising strategy for developing new cancer treatments. Credit: Tada Images/Shutterstock. Boehringer Ingelheim and ...

The rise in research and development activities in schizophrenia treatment is driving market growth by fostering the development of innovative therapies, including novel antipsychotics and ...

"We continue to pursue claims against Boehringer Ingelheim for its wrongdoing in exposing millions of people to a known carcinogen for over a decade. Our fight against Boehringer Ingelheim ...

German family-owned pharma major Boehringer Ingelheim and USA-based Circle Pharma (have entered into a research collaboration and license agreement with the shared goal to develop a first-in-class ...

FRANKFURT (Reuters) – Denmark’s Zealand Pharma and German partner Boehringer Ingelheim have won the U.S. Food and Drug Administration’s Breakthrough Therapy for the review of their experimental weight ...

FRANKFURT (Reuters) – Denmark’s Zealand Pharma and German partner Boehringer Ingelheim have won the U.S. Food and Drug Administration’s Breakthrough Therapy for the review of their ...

The 2024 calendar year gave the United States a golden opportunity to return themselves to the top of the women's football hierarchy after a slip in the previous four-year World Cup cycle.